Ocugen (OCGN) Debt to Equity (2014 - 2026)

Ocugen (OCGN) reported Debt to Equity of $5.03 for Q1 2026, up 189.25% on a YoY basis from $1.74 in Q1 2025, and up 312.5% quarter-over-quarter from -$2.37 in Q4 2025.

Ocugen (OCGN) Debt to Equity (2014 - 2026) Analysis & Trends

Ocugen has reported Debt to Equity for 13 years, with the latest figure at $5.03 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity rose 189.25% year-over-year to $5.03; the trailing twelve-month figure through Mar 2026 stood at $5.03 (up 189.25% YoY), and the FY2025 full-year result was -$2.37, down 344.59% from the prior year.
  • Debt to Equity for Q1 2026 stood at $5.03, up from -$2.37 in the prior quarter.
  • The five-year high for Debt to Equity was $9.18 in Q2 2025, with the low at -$2.37 in Q4 2025.
  • Historically, Debt to Equity has averaged $1.37 across 5 years, with a median of $0.07 in 2023.
  • The largest YoY upside for Debt to Equity was 11212.92% in 2025 against a maximum downside of 344.59% in 2025.
  • Ocugen's Debt to Equity stood at $0.03 in 2022, then surged by 123.1% to $0.07 in 2023, then jumped by 1301.73% to $0.97 in 2024, then sank by 344.59% to -$2.37 in 2025, then soared by 312.5% to $5.03 in 2026.
  • The last three Debt to Equity figures came in at $5.03 (Q1 2026), -$2.37 (Q4 2025), and $8.04 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ocugen 411.07 Mn 411.07 Mn - 5.03

Historic Data

Download Data
DateValue
Mar 31, 2026 5.03
Dec 31, 2025 -2.37
Sep 30, 2025 8.04
Jun 30, 2025 9.18
Mar 31, 2025 1.74
Dec 31, 2024 0.97
Sep 30, 2024 0.07
Jun 30, 2024 0.17
Mar 31, 2024 0.09
Dec 31, 2023 0.07
Sep 30, 2023 0.06
Jun 30, 2023 0.05
Mar 31, 2023 0.04
Dec 31, 2022 0.03
Sep 30, 2022 0.03
Jun 30, 2022 0.02
Mar 31, 2022 0.01
Dec 31, 2021 0.02
Sep 30, 2021 0.02
Jun 30, 2021 0.01